RXC-008

N/A

Report date: 2024/06/12 11:59:24
NMEFirst In Class

Base Information

Drug NameRXC-008
Drug Alias NameRXC-008RXC008
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho-associated kinases inhibitors
TargetsRho-associated kinases
Therapy Area/IndicationsCrohn Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRedx Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRedx Pharma Ltd
Inactive CompaniesN/A
Active IndicationsCrohn Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A